Pharmaceutical Consulting Firm Launches Clinical Pharma Compliance Exchange (PCX) Website
Philadelphia, PA, July 02, 2009 --(PR.com)-- Compliance Implementation Services (CIS), a pharmaceutical consulting firm based in Philadelphia, PA and Raleigh, NC, is pleased to announce the launch of its newest product, Pharma Compliance Exchange (PCX) for Clinical Research and Development professionals.
The Clinical R&D PCX website was developed by CIS to bring accessibility and order to the ever-expanding laws, regulations and guidelines required to conduct pharmaceutical clinical research. The website contains regulations and guidelines for the United States, European Union, and International Conference on Harmonization. The topics archived in the website include Clinical Trial Application, Clinical Trial Conduct, Study Sites and IRBs/ECs, Drug Safety and Marketing Authorization.
“We saw an industry need for a single online reference for regulations and guidelines governing clinical research and development activity,” said Annette Horner, Senior Director, Clinical Compliance. “We recognize the struggle and importance of keeping up to date with these regulations, so having this information organized and in one location is an easy solution for our subscribers.”
In addition to the Clinical R&D PCX serving as a reference guide, it also provides weekly updates and a ‘Hot Topics’ section, which lists the newest regulations posted to the website.
The Clinical R&D PCX was officially launched this past May, and CIS looks forward to feedback from industry users and to continuing improvements to the website.
About CIS:
Compliance Implementation Services (CIS) is a consulting firm specializing in compliance strategies for pharmaceutical companies, from Global Clinical Research & Development through U.S. Commercial Compliance. Founded in 2004 by industry experts, our deep understanding of industry laws and regulations, innovative and practical applications and custom solutions, help our clients establish a “Culture of Compliance.”
Our expertise allows us to understand and specialize in interpreting and implementing legal and regulatory requirements that have the greatest impact on research, development and commercial activities, so you can proactively identify and integrate appropriate compliance strategies.
###
The Clinical R&D PCX website was developed by CIS to bring accessibility and order to the ever-expanding laws, regulations and guidelines required to conduct pharmaceutical clinical research. The website contains regulations and guidelines for the United States, European Union, and International Conference on Harmonization. The topics archived in the website include Clinical Trial Application, Clinical Trial Conduct, Study Sites and IRBs/ECs, Drug Safety and Marketing Authorization.
“We saw an industry need for a single online reference for regulations and guidelines governing clinical research and development activity,” said Annette Horner, Senior Director, Clinical Compliance. “We recognize the struggle and importance of keeping up to date with these regulations, so having this information organized and in one location is an easy solution for our subscribers.”
In addition to the Clinical R&D PCX serving as a reference guide, it also provides weekly updates and a ‘Hot Topics’ section, which lists the newest regulations posted to the website.
The Clinical R&D PCX was officially launched this past May, and CIS looks forward to feedback from industry users and to continuing improvements to the website.
About CIS:
Compliance Implementation Services (CIS) is a consulting firm specializing in compliance strategies for pharmaceutical companies, from Global Clinical Research & Development through U.S. Commercial Compliance. Founded in 2004 by industry experts, our deep understanding of industry laws and regulations, innovative and practical applications and custom solutions, help our clients establish a “Culture of Compliance.”
Our expertise allows us to understand and specialize in interpreting and implementing legal and regulatory requirements that have the greatest impact on research, development and commercial activities, so you can proactively identify and integrate appropriate compliance strategies.
###
Contact
Compliance Implementation Services
Jacqueline O'Connor
484-445-7184
www.cis-partners.com
Jacqueline O'Connor
484-445-7184
www.cis-partners.com
Contact
Categories